New Guidelines for Severe Community-acquired Pneumonia
Thieme. All rights reserved..
In 2023, the new European guidelines on severe community-acquired pneumonia, providing clinical practice recommendations for the management of this life-threatening infection, characterized by a high burden of mortality, morbidity, and costs for the society. This review article aims to summarize the principal evidence related to eight different questions covered in the guidelines, by also highlighting the future perspectives for research activity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Seminars in respiratory and critical care medicine - 45(2024), 2 vom: 28. Apr., Seite 274-286 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Calabretta, Davide [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 15.04.2024 Date Revised 15.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1055/s-0043-1777797 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369187199 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369187199 | ||
003 | DE-627 | ||
005 | 20240415233316.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240302s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1055/s-0043-1777797 |2 doi | |
028 | 5 | 2 | |a pubmed24n1376.xml |
035 | |a (DE-627)NLM369187199 | ||
035 | |a (NLM)38428839 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Calabretta, Davide |e verfasserin |4 aut | |
245 | 1 | 0 | |a New Guidelines for Severe Community-acquired Pneumonia |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.04.2024 | ||
500 | |a Date Revised 15.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Thieme. All rights reserved. | ||
520 | |a In 2023, the new European guidelines on severe community-acquired pneumonia, providing clinical practice recommendations for the management of this life-threatening infection, characterized by a high burden of mortality, morbidity, and costs for the society. This review article aims to summarize the principal evidence related to eight different questions covered in the guidelines, by also highlighting the future perspectives for research activity | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Martìn-Loeches, Ignacio |e verfasserin |4 aut | |
700 | 1 | |a Torres, Antoni |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Seminars in respiratory and critical care medicine |d 1997 |g 45(2024), 2 vom: 28. Apr., Seite 274-286 |w (DE-627)NLM093752415 |x 1098-9048 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2024 |g number:2 |g day:28 |g month:04 |g pages:274-286 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/s-0043-1777797 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 45 |j 2024 |e 2 |b 28 |c 04 |h 274-286 |